Trial Profile
Safety trial of eriburin treatment to patient who has peripheral neuropathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Mar 2019
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 28 Feb 2019 Status changed from not yet recruiting to completed.
- 04 Sep 2012 New trial record